Overview

* Geron Q3 2025 revenue rises to $47.2 mln, driven by RYTELO sales

* Net loss for Q3 2025 narrows to $18.4 mln from $26.4 mln in 2024

* Operating income for Q3 2025 beats analyst expectations

Outlook

* Company expects 2025 operating expenses between $250 mln and $260 mln

* Company anticipates IMpactMF interim analysis in H2 2026

* Geron ( GERN ) believes existing resources and RYTELO sales will fund future operations

Result Drivers

* RYTELO SALES - Achieved $47.2 mln in net product revenue for Q3 2025, despite a 3% decline in demand

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $47.16

Product mln

Revenue

Q3 EPS -$0.03

Q3 Net -$18.42

Income mln

Q3 Beat -$13.88 -$17.30

Operatin mln mln (7

g Income Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

* Wall Street's median 12-month price target for Geron Corp ( GERN ) is $4.00, about 71.3% above its November 4 closing price of $1.15

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)